Synthetic Biologics (SYN) Files to Offer $40M in Common Stock
Tweet Send to a Friend
Synthetic Biologics (NYSE: SYN) disclosed in an SEC filing:On August 5, 2016, Synthetic Biologics, Inc. (the “Company”) and FBR Capital ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
